Polypeptide Group Ag (0AAJ)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 0AAJ market cap is 0. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 223.03M | 282.13M | 280.98M | 320.37M | 336.79M |
| Operating Income | 44.38M | 64.17M | 12.61M | -36.47M | -7.36M |
| Net Income | 31.34M | 47.26M | 7.77M | -51.44M | -19.56M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 375.98M | 595.04M | 575.78M | 689.09M | 756.58M |
| Total Liabilities | 198.32M | 173.87M | 154.11M | 307.86M | 399.33M |
| Total Equity | 177.66M | 421.17M | 421.68M | 381.23M | 357.24M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 49.74M | 57.35M | 5.46M | 36.49M | 89.4M |
| Investing | -42.82M | -80.85M | -78.44M | -59.51M | -91.02M |
| Financing | -6.73M | 130.93M | -26.87M | 84.55M | -25.32M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 33.13M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Polypeptide Group Ag |
| Address |
dammstrasse 19 zug 6300 |
| Website | https://www.polypeptide.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
